The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
about
Community acquired bacterial pneumoniaWhat is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.Comparison of immunoglobulin G subclass concentrations in severe community-acquired pneumonia and severe pandemic 2009 influenza A (H1N1) infection.The impact of bacterial and viral co-infection in severe influenzaAetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study.Burden of pneumococcal disease in adults aged 65 years and older: an Australian perspectiveInfection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.Clinical features of endemic community-acquired psittacosis.Evaluation of yield of currently available diagnostics by sample type to optimize detection of respiratory pathogens in patients with a community-acquired pneumoniaBacterial etiologies of five core syndromes: laboratory-based syndromic surveillance conducted in Guangxi, China.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controlsAcute lower respiratory infections in ≥ 5 year -old hospitalized patients in Cambodia, a low-income tropical country: clinical characteristics and pathogenic etiologyEstimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniquesEtiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China.Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia.Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in NorwayMortality Risk and Etiologic Spectrum of Community-acquired Pneumonia in Hospitalized Adult Patients.Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumoniaMacrolide resistance in Mycoplasma pneumoniae, Israel, 2010Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational studyCommunity-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia.Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired PneumoniaSystematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae.Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study.Utility of oropharyngeal real-time PCR for S. pneumoniae and H. influenzae for diagnosis of pneumonia in adults.Legionella pneumophila lung abscess associated with immune suppression.Viral infection in patients with severe pneumonia requiring intensive care unit admission.Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians.Pneumonia in the developing world: Characteristic features and approach to management.The SMART-COP score performs well for pneumonia risk stratification in Australia's Tropical Northern Territory: a prospective cohort study.Community-acquired pneumonia in the central desert and north-western tropics of Australia.Impact of an antimicrobial stewardship intervention on appropriateness of prescribing for community-acquired pneumonia in an Australian regional hospital.Procalcitonin as a Marker of Etiology in Adults Hospitalized with Community-Acquired Pneumonia.Identification of pathogens by comprehensive real-time PCR versus conventional methods in community-acquired pneumonia in Japanese adults.Management of community-acquired pneumonia in an Australian regional hospital.
P2860
Q22241379-6A963D87-599D-4457-8ABB-0B267BEC5455Q26852219-7A0BE1B3-BA9F-4D7D-AA70-2799028C79EEQ30234952-A1108043-6F61-4242-B8F8-3E6282D0BA2EQ30411633-9FC13B8D-6C10-4512-A3BF-9CCF2ED133F6Q30415172-8AFAA918-A9CC-4CCC-B7E0-B94F4DBF763FQ30416227-6A900280-3FEE-4801-B37E-8F0AB464C7E8Q30422390-63B3006E-5D8D-478D-B330-F3C9881950E1Q33802151-5B2AF483-F9DC-40BA-A623-439329A3B362Q33861071-D0CA963C-C3EF-4585-8917-CFB1B195862BQ34286621-63A4A031-672A-4C05-84D7-D5910B647E36Q34292704-B0190C69-EC97-472E-8B9B-479D609F8AD7Q34434577-D74ABE96-A257-446C-B235-6DDAE40D5F70Q34478074-2DBA12AF-D96C-4A59-A42D-ADBC93F5621EQ34539087-8A3F6931-2A10-416B-AB50-C453BA85F0E7Q34595933-3D89106B-6C37-4BD9-B188-A58D83B5C186Q34658291-E072CCCB-4962-4545-8DCB-E95378AA9AE2Q34802736-1857D8A1-BC55-4193-90FB-50BE63D81414Q35008394-7686AFD4-B143-4472-8E03-5DCFDD2128D6Q35102442-A585AD41-6C0C-4F1B-85BC-4C1E66075E6AQ35154780-B97A79E2-C9C2-4E22-8776-5469947A8559Q35745680-626407CB-0423-40FF-9842-DEA3FCEF300CQ35980166-8619D2B8-A5B9-4378-A455-04CC6817CB4FQ36281234-C607F5F5-42F4-42F4-B9E3-50445A347244Q36397026-6A5724F7-8848-49CC-B53B-6FD2B521F190Q36506099-A4D05856-9D95-4443-A3FE-C9DB2E16439FQ36660469-65FD76B1-2478-4B63-9464-F83F85729B87Q36676363-E432B0BB-0838-4269-9F56-8F9A35EC62A1Q36971154-3709BF11-7B40-417B-8654-C15D92E2BDDDQ37640327-CE1D9230-55CE-418D-A6DC-F24A75204A7EQ37642097-3B6A2C32-0BB0-4140-8164-39BDCDFA6114Q37995748-B27683F2-5506-4C97-8119-F628F13BB1DAQ38461590-8E226F40-EEC5-4E2D-8EDA-53B916FA8406Q38646554-1149DEC4-439B-4E4F-B515-37901F4DB035Q38691465-E5F2B192-EEA9-4043-AB28-2B8897FEE5E7Q39402565-B8D45EEB-2B6F-48DC-85A7-07B6732A9B54Q39416369-AC3415F6-AB1B-41FD-BDFC-F17D6D74AE54Q40213153-222EFF2D-BB91-45A7-9E89-C14555835791Q40243731-C6C9051F-1587-4866-AF89-A4415FAE75B7Q40688918-917DDFD9-E705-4910-8A47-962AA81A5247Q40863201-05B472ED-D24F-4E55-B629-7B279E692855
P2860
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The etiology of community-acqu ...... the most appropriate therapy.
@en
The etiology of community-acqu ...... the most appropriate therapy.
@nl
type
label
The etiology of community-acqu ...... the most appropriate therapy.
@en
The etiology of community-acqu ...... the most appropriate therapy.
@nl
prefLabel
The etiology of community-acqu ...... the most appropriate therapy.
@en
The etiology of community-acqu ...... the most appropriate therapy.
@nl
P2093
P2860
P356
P1476
The etiology of community-acqu ...... the most appropriate therapy.
@en
P2093
Alistair A Wright
Andrew J Fuller
Australian CAP Study Collaboration
Barbara Johnson
Barrie C Mayall
Graeme R Nimmo
Grant W Waterer
John G Armstrong
Keryn J Christiansen
M L Grayson
P2860
P304
P356
10.1086/586749
P407
P577
2008-05-01T00:00:00Z